Page
%P
-
Article
Open AccessTargeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells
Neuroblastoma (NB) is one of the most common childhood malignancies. Currently, high risk NB carries a poor outcome and significant treatment related toxicities and, thus has been a focus for new therapeutics ...